Add BrightSurf on Google Email

New research reveals two types of fatty liver disease

Researchers at Karolinska Institutet have identified two types of metabolic-associated fatty liver disease, a liver-specific type and a systemic type that affects other organs. The discovery could lead to improved diagnosis and treatment of this growing patient group, with potential benefits for cardiovascular health.

SourceKarolinska Institutet·JournalNature Medicine·DateDec 9, 2024

Association of waist circumference with all-cause and cardiovascular mortality in diabetes from the National Health and Nutrition Examination Survey 2003–2018

A U-shaped association between waist circumference and all-cause mortality was found in women, while a J-shaped trend was observed in men with type 2 diabetes. The study suggests that optimal waist circumference thresholds for minimizing mortality risk are 107 cm for women and 89 cm for men.

New hope for diabetic heart disease treatment

Researchers at Monash University have discovered that LXA4 can halve inflammation and scar formation in diabetic hearts, offering a promising new treatment option. The study's findings suggest that LXA4-based therapies could be used to manage diabetic heart disease more effectively.

SourceMonash University·JournalCardiovascular Diabetology·TypeExperimental study·DateNov 20, 2024

Proactively screening diabetics for heart disease does not improve long-term mortality rates or reduce future cardiac events, new study finds

Proactive screening of diabetic patients with coronary heart disease does not improve long-term survival rates or lower future cardiac events, according to a new study. The study found that focusing on proven interventions like medication management and lifestyle changes can help patients with diabetes lead healthier lives.

UAB researchers cure liver disease MASH by a one-time gene therapy

Researchers from UAB have developed a gene therapy that reverses metabolic dysfunction-associated steatohepatitis (MASH) in mice, and most obese and type 2 diabetic patients could benefit from this treatment. The therapy, based on the fibroblast growth factor 21 protein, mediates long-term reversal of liver fibrosis and MASH.

SourceUniversitat Autonoma de Barcelona·JournalMolecular Therapy·TypeExperimental study·DateNov 13, 2024

Lithuanian scientists are developing an ultrasound device to improve blood circulation and prevent diabetes complications in the lower extremities

Scientists from Kaunas University of Technology and Lithuanian University of Health Sciences developed a non-invasive ultrasonic foot stimulation device to improve blood circulation in the lower limbs. The device uses low-frequency ultrasound to stimulate blood flow and regulate thrombogenesis, immune response, and inflammatory processes.

Study shows how high blood sugar increases risk of thrombosis

Researchers from Brazil's Center for Research on Redox Processes in Biomedicine found that high blood sugar can cause thrombosis by altering endothelial function and promoting platelet adhesion. They identified a specific molecular mechanism involving protein disulfide isomerase A1 as a key regulator of this process.

SourceFundação de Amparo à Pesquisa do Estado de São Paulo·JournalJournal of Thrombosis and Haemostasis·DateNov 6, 2024

Brighter nights and darker days could lead to an early grave

A study of over 13 million hours of data found that exposure to bright nights and dark days is associated with an increased risk of death. Those exposed to high levels of light at night had a 21–34% increased risk, while those exposed to high levels of daylight had a 17–34% reduction in their risk of death.

SourceFlinders University·JournalProceedings of the National Academy of Sciences·TypeData/statistical analysis·DateOct 30, 2024

Cardiovascular risk biomarkers in inflammaging

Researchers propose a comprehensive biomarker-based approach to assess cardiovascular risk by combining markers of chronic inflammation with cardiac health indicators. This approach reveals the significant impact of aging-related inflammation, or 'inflammaging,' on heart health and opens new avenues for targeted interventions.

SourceImpact Journals LLC·JournalAging-US·TypeCommentary/editorial·DateOct 29, 2024

Study finds bariatric surgery declined with rise in GLP-1 drugs to treat obesity

A recent study found that the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) as anti-obesity medications more than doubled from 2022 to 2023, while rates of metabolic bariatric surgery dropped by one quarter. This shift in treatment options has implications for access to comprehensive multidisciplinary care for obesity.

SourceBrigham and Women's Hospital·JournalJAMA Network Open·TypeObservational study·DateOct 25, 2024

Ozempic (and similar medications) may be the new treatment for opioid and alcohol use disorder

A new study found that people with opioid or alcohol use disorder who take Ozempic or similar medications have a lower rate of opioid overdose and alcohol intoxication. The medication, which treats diabetes and weight-related conditions, may also alter the brain's reward-response pathways associated with substance use.

SourceSociety for the Study of Addiction·JournalAddiction·TypeObservational study·DateOct 17, 2024

Brown researchers show how gut hormones control aging in flies and how it relates to human biology

Researchers at Brown University have found a way to extend the lifespan of flies by suppressing a hormone that regulates insulin secretion. The study suggests that certain medications used to treat human obesity and diabetes may also impact aging, making it a promising area of research for future studies.

SourceBrown University·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateOct 16, 2024

Early release from NEJM Evidence

Researchers have developed a new treatment for deep diabetic foot ulcers, using intact fish skin grafts to promote healing. The study found that this innovative approach showed promising results in improving wound closure and reducing infection rates.

SourceNEJM Group·JournalNEJM Evidence·DateOct 4, 2024

Study finds minorities more likely to have ‘free’ preventive healthcare denied by insurers

A new study published in JAMA Network Open found that racial and ethnic minorities are more likely to have claims for free preventive care denied by insurance plans, leading to unexpected bills or lack of access. Healthcare providers also charge disadvantaged groups a higher amount for preventive services.

SourceUniversity of Massachusetts Amherst·JournalJAMA Network Open·TypeData/statistical analysis·DateOct 3, 2024

Medical imaging breakthrough could transform cancer and arthritis diagnosis

A new hand-held scanner can generate highly detailed 3D images in seconds, paving the way for earlier disease diagnosis. The technology uses laser-generated ultrasound waves to visualize subtle changes in blood vessels, helping inform patient care and diagnose conditions like cancer and cardiovascular disease.

SourceUniversity College London·JournalNature Biomedical Engineering·TypeExperimental study·DateSep 30, 2024

Time-restricted eating associated with greater blood sugar control and fat loss than standard nutrition counseling

A randomized controlled trial found that time-restricted eating (TRE) led to greater improvements in glucose control, weight loss, and fat reduction compared to standard nutrition counseling in adults with metabolic syndrome. TRE resulted in a lower risk of muscle mass loss during weight loss.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeNews article·DateSep 30, 2024